The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
about
CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected IndividualsEstablishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonistsEmerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug usersKinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine familyDiverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophilsIdentification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replicationProteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteasesPotent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Novel compounds in preclinical/early clinical development for the treatment of HIV infections.Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in miceAccuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disordersPosttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activityRegulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.New anti-HIV agents and targets.CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.Chemokine receptors: emerging opportunities for new anti-HIV therapies.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Host genes important to HIV replication and evolution.CCL3L1 copy number and susceptibility to malaria.Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population.Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmissionCCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorderD6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.CCR1 as a target for multiple myeloma.Targeting CCR5 for anti-HIV research.CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.CD26 and Asthma: a Comprehensive Review.Population structure in copy number variation and SNPs in the CCL4L chemokine gene.CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection.CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis.Functional effects of CCL3L1 copy number.
P2860
Q19028101-7A02DB64-C6E0-4C86-AEEC-0D5BEFD7E363Q24802476-C3A1D6CA-0D23-4E4B-9AD1-99AE092676CFQ26739691-9B414731-06EE-4531-93CA-2AC34F15418DQ27491039-4D65CCFB-DD08-4106-8393-536CCF371C37Q28199376-9BB47155-6BA2-4DCB-95C3-5982EB32D6D5Q28205971-63458550-EC5A-4622-ADA3-AE78177D3CD5Q28209188-37287EC3-7DD0-494B-8018-F199D1E8B33DQ28236498-A7EC4DFA-B478-4699-BC4D-82ECA4D0C4B2Q28345395-387BC6E3-C4D7-4510-90DA-1D5CB053C6F2Q33383193-574E28CC-82D8-41C3-9C70-1D4087EBE4B6Q33827798-F05476CF-9AE5-4546-B319-24C33AB8B60BQ33966254-987CDA74-26BC-4344-B4AA-6DFCB0199E56Q33989839-6C6E6497-70DF-4013-AC48-66A7782DB7BCQ33996098-36E89282-11D9-4902-BB66-4732BD8A93F3Q34144597-5ECCE5C0-B4DA-4E26-9409-03C77DCBE659Q34309912-8070C42C-1AF2-4920-84E6-D50FB912854FQ34509644-0E23BF6D-B60A-4A9D-8293-D19B1DB123B4Q34944447-49346F11-2759-4D25-A617-024EFABE9484Q35039268-4D6FA46E-1751-4BF8-9725-858FD1559299Q35050395-9D603F0E-E10B-4E91-B975-B3FD310E0B4AQ35189265-E3F4B6AE-427F-4526-BAF0-3154CF10F33EQ35853016-5233D917-3C64-4499-847C-A4267055BF2BQ36106726-49727D47-61B1-4905-9E39-7CB20BD1B15DQ36303451-723B84F3-76FD-4F7D-B85D-96F036CCB23CQ36561807-8AC03E72-F4F7-417F-A32F-C5FD7AA3074EQ36628269-7CBE4683-AC14-4083-91CB-B777CEA7B047Q36956617-317DA603-E774-41A3-8610-519CAD11C4C5Q37364658-5CB93A2C-BD5A-407C-B5F4-B25BB2C56806Q37432097-0EF836D0-1657-4808-A786-84F23E6AA039Q37511474-330E1E86-CFF1-452C-9CE8-58C66A8EF029Q37775691-FDF5F24D-33F8-4288-BB9E-3199A759BC02Q37879210-C1050D0D-E391-4711-96C9-3ED2A69FA2FFQ38229805-A67F5D96-4D71-4436-8178-6894608B0BAFQ38690194-247DC5A9-9CDC-4D87-A45A-6778AC916CF1Q38877913-42EB109E-DB44-425A-8AA1-C298693C085AQ38937243-06184FB3-A143-4DBE-8418-8BAB95EA250EQ38951086-C6B8B65C-BD32-4FB7-83B7-618B9B86E075Q39030321-35C99181-CACB-4BC2-B5F2-598E191F9439Q41883527-FA20774B-7D0F-4B75-9F1B-3C63E6E81325Q42258047-034CABC2-B83E-4C82-9416-95E1F3B6D095
P2860
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@ast
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@en
type
label
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@ast
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@en
prefLabel
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@ast
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@en
P2093
P2860
P50
P356
P1476
The LD78beta isoform of MIP-1a ...... nd HIV-1-inhibiting chemokine.
@en
P2093
P2860
P356
10.1172/JCI7318
P407
P577
1999-08-01T00:00:00Z